During the past decade, Rheinhessen-Fachklinik Alzey conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheinhessen-Fachklinik Alzey" #1 sponsor was "Heinrich-Heine University, Duesseldorf" with 2 trials, followed by "Janssen-Cilag International NV" with 1 trials sponsored, "Otsuka Pharmaceutical Europe Ltd" with 1 trials sponsored, "Rheinhessen-Fachklinik Alzey" with 1 trials sponsored and "University Hospital, Bonn" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheinhessen-Fachklinik Alzey" #1 collaborator was "University Hospital Tuebingen" with 2 trials as a collaborator, "University of Cologne" with 2 trials as a collaborator, "Central Institute of Mental Health, Mannheim" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "H. Lundbeck A/S" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Rheinhessen-Fachklinik Alzey" are "Schizophrenia" (3 trials), "Depressive Disorder, Major" (1 trials), "Prodromal Schizophrenia" (1 trials), "Retrograde Amnesia" (1 trials) and "Schizoaffective Disorder" (1 trials). Many other conditions were trialed in "Rheinhessen-Fachklinik Alzey" in a lesser frequency.

Most popular intervention types in "Rheinhessen-Fachklinik Alzey" are "Drug" (3 trials), "Behavioral" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amisulpride" (1 trials), "Esketamine 28 mg" (1 trials), "Esketamine 56 mg" (1 trials), "Esketamine 84 mg" (1 trials) and "German Autobiographical Memory Interview short-form" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rheinhessen-Fachklinik Alzey" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Rheinhessen-Fachklinik Alzey". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rheinhessen-Fachklinik Alzey, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rheinhessen-Fachklinik Alzey, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".